Literature DB >> 21752049

Dermatomyofibromas presenting in pediatric patients: clinicopathologic characteristics and differential diagnosis.

Juan C Tardío1, Daniel Azorín, Almudena Hernández-Núñez, Ana Guzmán, Antonio Torrelo, Marisa Herráiz, Pablo Espinosa, Amalia Moreno, Rosario Granados, Isabel Colmenero.   

Abstract

Dermatomyofibroma represents a rare benign fibroblastic/ myofibroblastic cutaneous tumor that mostly occurs in young adult women. It has been seldom reported in pediatric patients. In this analysis, the clinical, histopathological and immunohistochemical findings of 12 dermatomyofibromas occurring in patients up to 16 years of age are compared with those reported in adults. Six patients were male and six were female. Nine lesions were located on the neck, two on the back and one involved the chest. The usual presentation was as an asymptomatic plaque composed of bland spindled cells arranged in dermal fascicles that were oriented parallel to the epidermis. Immunohistochemically, the lesional cells expressed calponin in 11 cases, smooth muscle actin in six and muscle-specific actin in three. In contrast to prior reports from adults, dermatomyofibromas in pediatric patients do not show a female predilection. In addition, they are mostly located on the neck (56%), while in adults the most frequent location is the shoulder (35%). Dermatomyofibromas seem to stabilize after an initial period of enlargement. Punch biopsy and clinical follow up could be an alternative approach to the surgical excision in some cases of dermatomyofibroma, particularly in instances in which surgery might inflict cosmetic defects.
Copyright © 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752049     DOI: 10.1111/j.1600-0560.2011.01739.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  1 in total

1.  Dermatomyofibroma.

Authors:  Orley Alvaro Campagnolo; Carlos Floriano de Morais; Marina Ochoa Ughini; Camile Mayumi Aoki; Marília Menegazzo
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.